IBIS BIOSCIENCES

USPTO USPTO 2006 ABANDONED - NO STATEMENT OF USE FILED

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke IBIS BIOSCIENCES wurde als Wortmarke am 23.03.2006 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - NO STATEMENT OF USE FILED".

Markendetails

Markenform Wortmarke
Aktenzeichen 78844201
Anmeldedatum 23. März 2006
Veröffentlichungsdatum 12. Februar 2008

Markeninhaber

1896 RUTHERFORD ROAD
92008 CARLSBAD
US

Markenvertreter

Waren und Dienstleistungen

42 Scientific and technological research services in the areas of analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others and leasing to others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for scientific and research use; development for others and leasing to others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for scientific and research use; development for others and leasing to others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific and research use; development for others and leasing to others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific and research use; development for others and leasing to others of computer software and hardware for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others and leasing to others of computer software and hardware for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for medical use; development for others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for medical use; development for others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; development for others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use
44 Leasing to others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for medical use; leasing to others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for medical use; leasing to others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; leasing to others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1378844201